Position in ACAD
as of Jun 30, 2026
· filed Jul 21, 2026
Position Value
$427,721
-$31,547 QoQ
Shares Held
16,906
-18.1% QoQ
Ownership
0.010%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#28
of 73 holders
Holding Since
Jun 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ACAD Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026J.W. COLE ADVISORS, INC. holds $3,075,638 across 11 Biotechnology names. ACAD ranks #4 (13.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,414 | $702,376 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
958 | $597,351 | |
| 3 | RVMD |
Revolution Medicines, Inc.
|
2,722 | $509,776 | |
| 4 | ACAD |
Acadia Pharmaceuticals Inc
This page
|
16,906 | $427,721 | |
| 5 | EXEL |
Exelixis, Inc.
|
5,934 | $322,868 | |
| 6 | INCY |
Incyte Corp
|
2,210 | $250,525 | |
| 7 | VCEL |
Vericel Corp
|
4,700 | $209,103 | |
| 8 | CRBU |
Caribou Biosciences, Inc.
|
11,269 | $19,833 |
All Filings in ACAD
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $427,721 | 16,906 | Shares | Sole | 2026-07-21 | |
| 2026-03-31 | $459,268 | 20,632 | Shares | Sole | 2026-04-23 | |
| 2025-12-31 | $551,080 | 20,632 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $429,595 | 20,131 | Shares | Sole | 2025-11-05 | |
| 2025-06-30 | $430,990 | 19,981 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $382,461 | 23,026 | Shares | Sole | 2025-05-05 | |
| 2024-12-31 | $323,327 | 17,620 | Shares | Sole | 2025-01-31 | |
| 2024-09-30 | $270,995 | 17,620 | Shares | Sole | 2024-10-24 | |
| 2024-06-30 | $286,325 | 17,620 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $325,793 | 17,620 | Shares | Sole | 2024-04-30 | |
| 2023-12-31 | $551,682 | 17,620 | Shares | Sole | 2024-01-31 | |
| 2023-09-30 | $367,200 | 17,620 | Shares | Sole | 2023-10-24 | |
| 2023-06-30 | $428,345 | 17,885 | Shares | Sole | 2023-07-27 | |
| 2023-03-31 | $336,595 | 17,885 | Shares | Sole | 2023-05-03 | |
| 2022-12-31 | $284,729 | 17,885 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $292,598 | 17,885 | Shares | Sole | 2022-10-31 | |
| 2022-06-30 | $251,999 | 17,885 | Shares | Sole | 2022-07-27 | |
| 2022-03-31 | $433,780 | 17,910 | Shares | Sole | 2022-06-10 | |
| 2021-12-31 | $418,019 | 17,910 | Shares | Sole | 2022-01-25 | |
| 2021-09-30 | $297,485 | 17,910 | Shares | Sole | 2021-10-26 | |
| 2021-06-30 | $436,824 | 17,910 | Shares | Sole | 2021-08-06 | |
| 2021-03-31 | $461,433 | 17,885 | Shares | Sole | 2021-04-28 | |
| 2020-12-31 | $985,214 | 18,429 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $792,165 | 19,204 | Shares | Sole | 2020-11-05 | |
| 2020-06-30 | $868,582 | 17,920 | Shares | Sole | 2020-08-07 | |
| No filing history on record for this holder in this stock. | ||||||